Last updated on November 2017

Patients needed for migraine study "Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine"


Brief description of study

Patients needed for migraine study "Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine"

Detailed Study Description

This research study is being conducted for patients experiencing migraines. This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single migraine attack.

Clinical Study Identifier: TX82069

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Patient Recruitment

Cedar Crosse Research Center
Chicago, IL USA
  Connect »